The United States FDA has granted marketing approval to a new drug to help treat schizophrenia. Called Fanapt (iloperidone), the medication is intended to treat adults with schizophrenia while in the acute phases. It isn’t yet known how long they should be kept on the medication once the acute phases is over, but researchers agree that if the patient is responding, continuing with the treatment is encouraged.

According to a company press release , “The approval was supported by two placebo-controlled Phase III clinical studies comparing Fanapt(TM) to placebo and active control in patients with schizophrenia, as well as safety data …read more

During Celebrity Health Week, I wrote two posts about schizophrenia: Celebrities and Schizophrenia and Tell Me More about Schizophrenia: Signs, Symptoms, and Treatments.
However, had I known about NAMI’s Schizophrenia: Public Attitudes, Personal Needs Web site I would have definitely included it.
The Web site:

Gives a summary of the schizophrenia survey. For example, did you know an average time period of eight and a half years passes between the time a person’s schizophrenia symptoms first surface until the time the person first receives schizophrenia treatment? You can also see the methodology of the survey.
Provides an analysis section, broken down into three parts …read more